PHARM-BIO SERV INC lost $0.00 per diluted share in fiscal year 2025. This represents an increase of 88.2% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $0.00 per diluted share. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters PHARM-BIO SERV INC has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was PHARM-BIO SERV INC's diluted earnings per share in fiscal year 2025?
PHARM-BIO SERV INC lost $0.00 per diluted share in fiscal year 2025.
How fast is PHARM-BIO SERV INC's diluted earnings per share growing?
PHARM-BIO SERV INC (PBSV) diluted earnings per share rose by 88.2% year over year, from -$0.03 to $0.00 in fiscal year 2025.
What is PHARM-BIO SERV INC's diluted earnings per share over the last twelve months?
PHARM-BIO SERV INC (PBSV) reported $0.00 per diluted share over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
How has PHARM-BIO SERV INC's diluted earnings per share changed over the years?
Across the 15 fiscal years this page covers, PHARM-BIO SERV INC (PBSV) diluted earnings per share went from $0.14 in fiscal year 2011 to $0.00 in fiscal year 2025.
What was PHARM-BIO SERV INC's diluted earnings per share in the most recent quarter?
PHARM-BIO SERV INC (PBSV) reported $0.00 in diluted earnings per share in Q3 2026.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what PHARM-BIO SERV INC (PBSV) reported on that line in every period on record.